Showing results (1-10 of 254) with videos related to
Sort By:
Pageof 26
Frontiers in Pharmacology|April 17, 2023
Endothelial KCa channels: Novel targets to reduce atherosclerosis-driven vascular dysfunctionO Daniel Vera, Heike Wulff, Andrew P BraunCardiovascular Research|November 3, 2012
SKA-31, a novel activator of SK(Ca) and IK(Ca) channels, increases coronary flow in male and female rat heartsRamesh C Mishra, Darrell Belke, Heike Wulff, et al.Journal of Cardiovascular Pharmacology|March 28, 2015
Inhibition of Myogenic Tone in Rat Cremaster and Cerebral Arteries by SKA-31, an Activator of Endothelial KCa2.3 and KCa3.1 ChannelsRamesh C Mishra, Heike Wulff, Michael A Hill, et al.Journal of Molecular and Cellular Cardiology|May 3, 2014
A pharmacologic activator of endothelial KCa channels enhances coronary flow in the hearts of type 2 diabetic ratsRamesh C Mishra, Heike Wulff, William C Cole, et al.Frontiers in Pharmacology|March 17, 2025
Administration of the K<sub>Ca</sub> channel activator SKA-31 improves endothelial function in the aorta of atherosclerosis-prone miceO Daniel Vera, Ramesh C Mishra, Rayan Khaddaj-Mallat, et al.Metabolism: Clinical and Experimental|August 20, 2024
Targeting endothelial K<sub>Ca</sub> channels in vivo restores arterial and endothelial function in type 2 diabetic ratsRamesh C Mishra, Darrell D Belke, Latika Singh, et al.Physiological Reports|May 15, 2018
Alpha<sub>1</sub> -adrenergic stimulation selectively enhances endothelium-mediated vasodilation in rat cremaster arteriesRamesh C Mishra, Mohammad M Rahman, Michael J Davis, et al.Expert Opinion on Therapeutic Patents|October 20, 2010
Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers: WO2010066840Heike WulffVascular Pharmacology|August 5, 2015
A pharmacologic activator of endothelial KCa channels increases systemic conductance and reduces arterial pressure in an anesthetized pig modelRamesh C Mishra, Jamie R Mitchell, Carol Gibbons-Kroeker, et al.Pageof 26